CO4940415A1 - CHEMICAL COMPOUND - Google Patents
CHEMICAL COMPOUNDInfo
- Publication number
- CO4940415A1 CO4940415A1 CO98011404A CO98011404A CO4940415A1 CO 4940415 A1 CO4940415 A1 CO 4940415A1 CO 98011404 A CO98011404 A CO 98011404A CO 98011404 A CO98011404 A CO 98011404A CO 4940415 A1 CO4940415 A1 CO 4940415A1
- Authority
- CO
- Colombia
- Prior art keywords
- chemical compound
- sodium salt
- hydrated form
- crystalline hydrated
- phenylpiro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
La sal de sodio del ácido (E) 4,6-dicloro-3-(2-oxo-1-fenilpirro-lidin-3-ilideno metil)-1H-indol-2-carboxílico, en una forma hidratada cristalina.Un proceso para la preparación de una forma hidratada cristalina como se define en cualesquiera de las reivindicaciones 1 a 4, caracterizado porque comprende la cristalización de la sal de sodio a partir de una solución de un alcanol acuosos".The sodium salt of (E) 4,6-dichloro-3- (2-oxo-1-phenylpiro-lidin-3-ylidene methyl) -1H-indole-2-carboxylic acid, in a crystalline hydrated form. for the preparation of a crystalline hydrated form as defined in any one of claims 1 to 4, characterized in that it comprises the crystallization of the sodium salt from a solution of an aqueous alkanol ".
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4940415A1 true CO4940415A1 (en) | 2000-07-24 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98011404A CO4940415A1 (en) | 1997-03-05 | 1998-03-03 | CHEMICAL COMPOUND |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (en) |
| JP (1) | JP2001513796A (en) |
| KR (1) | KR20000075907A (en) |
| CN (1) | CN1249750A (en) |
| AP (1) | AP9901637A0 (en) |
| AR (1) | AR011178A1 (en) |
| AU (1) | AU6825198A (en) |
| BG (1) | BG103779A (en) |
| BR (1) | BR9808305A (en) |
| CA (1) | CA2282851A1 (en) |
| CO (1) | CO4940415A1 (en) |
| EA (1) | EA199900710A1 (en) |
| EE (1) | EE9900387A (en) |
| GB (1) | GB9704498D0 (en) |
| HR (1) | HRP980114A2 (en) |
| HU (1) | HUP0002109A2 (en) |
| ID (1) | ID24207A (en) |
| IL (1) | IL131489A0 (en) |
| IS (1) | IS5166A (en) |
| NO (1) | NO994303L (en) |
| NZ (1) | NZ337315A (en) |
| OA (1) | OA11154A (en) |
| PE (1) | PE51399A1 (en) |
| PL (1) | PL335652A1 (en) |
| SK (1) | SK119699A3 (en) |
| TR (1) | TR199902117T2 (en) |
| WO (1) | WO1998039327A1 (en) |
| YU (1) | YU43499A (en) |
| ZA (1) | ZA981791B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| AU2018284335A1 (en) | 2017-06-12 | 2020-01-30 | Glytech Llc. | Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 PE PE1998000149A patent/PE51399A1/en not_active Application Discontinuation
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/en unknown
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Ceased
- 1998-03-03 AR ARP980100948A patent/AR011178A1/en unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/en active Pending
- 1998-03-03 JP JP53813598A patent/JP2001513796A/en active Pending
- 1998-03-03 YU YU43499A patent/YU43499A/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/en unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/en unknown
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/en not_active Application Discontinuation
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/en unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/en not_active Withdrawn
- 1998-03-03 PL PL98335652A patent/PL335652A1/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/en unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/en unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/en unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/en unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/en not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/en unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/en unknown
- 1999-09-03 NO NO994303A patent/NO994303L/en not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337315A (en) | 2001-02-23 |
| SK119699A3 (en) | 2000-05-16 |
| YU43499A (en) | 2000-12-28 |
| PL335652A1 (en) | 2000-05-08 |
| PE51399A1 (en) | 1999-06-07 |
| WO1998039327A1 (en) | 1998-09-11 |
| NO994303L (en) | 1999-11-03 |
| EE9900387A (en) | 2000-04-17 |
| IS5166A (en) | 1999-08-27 |
| CA2282851A1 (en) | 1998-09-11 |
| HUP0002109A2 (en) | 2001-04-28 |
| TR199902117T2 (en) | 2000-03-21 |
| AU6825198A (en) | 1998-09-22 |
| BG103779A (en) | 2000-06-30 |
| KR20000075907A (en) | 2000-12-26 |
| GB9704498D0 (en) | 1997-04-23 |
| OA11154A (en) | 2003-04-16 |
| NO994303D0 (en) | 1999-09-03 |
| EA199900710A1 (en) | 2000-04-24 |
| IL131489A0 (en) | 2001-01-28 |
| ZA981791B (en) | 1999-09-03 |
| AP9901637A0 (en) | 1999-09-30 |
| JP2001513796A (en) | 2001-09-04 |
| EP0966463A1 (en) | 1999-12-29 |
| HRP980114A2 (en) | 1998-12-31 |
| ID24207A (en) | 2000-07-13 |
| BR9808305A (en) | 2000-05-16 |
| AR011178A1 (en) | 2000-08-02 |
| CN1249750A (en) | 2000-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR061765A2 (en) | PROCESS FOR THE PREPARATION OF PRAVASTATIN SODIUM SALT IN A CRYSTAL FORM | |
| FI20002767A0 (en) | Iodine salts as latent acid donors | |
| PT1177176E (en) | DERIVATIVES OF TRIARILIC ACIDS AS LIGANDS OF PPAR RECEPTORS. | |
| AR043266A2 (en) | CRYSTAL FORM OF THE MONOMETANSULPHONIC ACID ADDITION SALT OF A N-PHENYL-2-PYRIMIDINAMINE DERIVATIVE | |
| GT199900055A (en) | NEW DIETHYDROPYRIMIDINES2 HETEROCYCLICALLY SUBSTITUTED. | |
| GT199900199A (en) | COMPOSITIONS OF HIGHLY CONCENTRATED Aqueous GLISOPHATE. | |
| DK1163207T3 (en) | Improved process for the preparation of non-hygroscopic salts of L (-) - carnitine | |
| DE60334678D1 (en) | ANTIBODY-CONTAINING PHARMACEUTICAL SOLUTIONS | |
| ATE526022T1 (en) | STABILIZED COMPOSITIONS CONTAINING BENZIMIDAZOLES | |
| CO5580776A2 (en) | STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN | |
| PT1252170E (en) | SELECTIVE CRYSTALLIZATION OF SODIUM 3-PYRIDYL-1-HYDROXYETHYDIDENE-1,1-BISPHOSPHONIC ACID AS HEMIPENTAHYDRATE OR MONOHYDRATE | |
| NO20034393L (en) | Double feeding system for solid-state chemical | |
| ES2187261B2 (en) | ETERES AND AMIDAS COMPOUNDS AND THEIR PREPARATION, AS ANTI-DIABETIC AGENTS. | |
| DK0797426T3 (en) | Formation of stable aqueous solutions of tin compounds | |
| NO964121D0 (en) | Pyrimidine or triazine carboxylic acid derivatives for use as drugs | |
| CO4940415A1 (en) | CHEMICAL COMPOUND | |
| PT828721E (en) | 2-AMINO-BENXOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | |
| ATE181957T1 (en) | PASTE CLEANING AGENT | |
| EA200101150A1 (en) | PRUNCTIONAL SOLUTION FOR ORAL APPLICATION | |
| ES2075454T3 (en) | PURE CRYSTALLINE FORM OF RIFAPENTINE. | |
| TR200001121T2 (en) | Antirheumatic substance. | |
| ITBO990621A0 (en) | CIGAR FEEDING UNIT. | |
| DK1239935T3 (en) | Anti-foaming agent and its use | |
| BR0107483A (en) | Process for the preparation of a compound | |
| ES2183649T3 (en) | METHOD FOR MANUFACTURING FORMAT OF AN ALKALINE METAL OR OF AN ALKALINOTERAL METAL. |